Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.44 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | ACR | P10323 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | MMP13 | P45452 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5826354 | 0.92 | LMNA (0.55) | LMNAALDH1A1KMT2AL3MBTL1PTK2B | |
| P-Xylene SCHEMBL28920520 | 0.89 | LMNA (0.52) | LMNAALDH1A1KMT2AL3MBTL1PTK2B | |
| SCHEMBL6924446 | 0.87 | RAB9A (0.46) | LMNAALDH1A1GAAKMT2ARAB9A | |
| Toluene SCHEMBL5727027 | 0.85 | LMNA (0.47) | LMNAALDH1A1TSHRKMT2AACHE | |
| SCHEMBL8467442 | 0.82 | LMNA (0.59) | LMNAALDH1A1CYP3A4TSHRGAA | |
| SCHEMBL219040 | 0.81 | CES2 (0.54) | LMNAALDH1A1TSHRGAACYP1A2 | |
| SCHEMBL7064531 | 0.80 | LMNA (0.70) | LMNAALDH1A1CYP3A4TSHRGAA | |
| SCHEMBL47792 | 0.80 | LMNA (0.70) | LMNAALDH1A1CYP3A4TSHRGAA | |
| SCHEMBL6565732 | 0.80 | HSD17B10 (0.47) | LMNAALDH1A1GAAKMT2ACYP1A2 | |
| SCHEMBL6564201 | 0.80 | ELANE (0.52) | LMNAALDH1A1TSHRKMT2ARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 713 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4635941-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2025-10-22 | — | — | EP | claimed |
| EP-4471010-B1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INT BV (NL) | 2025-06-04 | — | — | EP | claimed |
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | NOURYON CHEMICALS INTERNATIONAL B.V. (NL) | 2024-12-05 | — | — | US | claimed |
| EP-4471010-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | Nouryon Chemicals International B.V. (NL) | 2024-12-04 | — | — | EP | claimed |
| CN-119059951-A | Process for preparing peroxyesters or peroxycarbonates | 诺力昂化学品国际有限公司 | 2024-12-03 | — | — | CN | claimed |
| EP-3617195-B1 | NOVEL TETRAHYDRONAPHTHYL UREA DERIVATIVES AS INHIBITORS OF TROPOMYOSIN RECEPTOR KINASE A FOR THE TREATMENT OF PAIN | MOCHIDA PHARM CO LTD (JP) | 2024-08-28 | — | — | EP | claimed |
| EP-3617195-A1 | NOVEL TETRAHYDRONAPHTHYL UREA DERIVATIVES | Mochida Pharmaceutical Co., Ltd. (JP) | 2020-03-04 | — | — | EP | claimed |
| CN-110831926-A | Novel tetralinyl urea derivatives | 持田制药株式会社 | 2020-02-21 | — | — | CN | claimed |
| WO-2019189717-A1 | METHOD FOR PRODUCING TETRAHYDRONAPHTHYLUREA DERIVATIVE | 持田製薬株式会社 | 2019-10-03 | — | — | WO | claimed |
| EP-2373633-B1 | METHOD FOR PRODUCING TRAZINE CARBAMATES USING CHLOROFORMATES | BOREALIS AGROLINZ MELAMINE (AT) | 2014-04-16 | — | — | EP | claimed |
| US-20110295001-A1 | Method for Producing Triazine Carbamates Using Chloroformates | BOREALIS AGROLINZ MELAMINE GMBH (AT) | 2011-12-01 | — | — | US | claimed |
| WO-1995025083-A1 | PROCESS FOR THE PREPARATION OF ARYL HALOFORMATES AND DIARYL CARBONATES | GALVAN, RAFAEL | 1995-09-21 | — | — | WO | claimed |
| US-5424473-A | Process for the preparation of aryl haloformates and diaryl carbonates | THE DOW CHEMICAL COMPANY (US) | 1995-06-13 | — | — | US | claimed |
| EP-0019744-B1 | PROCESS FOR THE PREPARATION OF 3-NITRO-4-METHYLPHENYL CHLOROFORMATE | BASF Aktiengesellschaft (DE) | 1982-12-29 | — | — | EP | claimed |
| US-20260132111-A1 | Host-Targeted Pan-Respiratory Antiviral Small Molecule Therapeutics | PROSETTA BIOSCIENCES INC (US) | 2026-05-14 | — | — | US | disclosed |
| EP-3704094-B1 | MODULATORS OF THE INTEGRATED STRESS PATHWAY | CALICO LIFE SCIENCES LLC (US) | 2026-03-11 | — | — | EP | disclosed |
| EP-3788039-B1 | FACTOR XIIA INHIBITORS | UNIV LEEDS INNOVATIONS LTD (GB) | 2026-02-11 | — | — | EP | disclosed |
| US-4046770-A | IMMUNE REGULANTS | ELI LILLY AND COMPANY (US) | 1977-09-06 | — | — | US | disclosed |
| US-4003909-A | [(1,2,4-Oxadiazol-3-yl)phenyl]carbamic or thiocarbamic acid esters | E. R. SQUIBB & SONS, INC. (US) | 1977-01-18 | — | — | US | disclosed |
| US-3932434-A | IMMUNOSUPPRESSANTS | ELI LILLY AND COMPANY (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260132111-A1 | Host-Targeted Pan-Respiratory Antiviral Small Molecule Therapeutics | NCOR1, HAVCR2, NR3C1 | LMNA 2689/4885ALDH1A1 3991/4885CYP3A4 1969/4885 |
| US-20110295001-A1 | Method for Producing Triazine Carbamates Using Chloroformates | CA3, CA7, KAT5 | LMNA 3030/4885ALDH1A1 1014/4885CYP3A4 464/4885 |
| US-20240400490-A1 | PROCESS FOR PREPARING A PEROXYESTER OR PEROXYCARBONATE | GPX4, PRDX4, PRDX2 | LMNA 1453/4885ALDH1A1 327/4885CYP3A4 204/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.